UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Impact of molecular residual disease post allografting in myelofibrosis patients

Bone marrow transplantation (Basingstoke), 2017-11, Vol.52 (11), p.1526-1529

2017

Volltextzugriff (PDF)

Toxicity-reduced, myeloablative allograft followed by lenalidomide maintenance as salvage therapy for refractory/relapsed myeloma patients

Bone marrow transplantation (Basingstoke), 2013-03, Vol.48 (3), p.403-407

2013

Volltextzugriff (PDF)

Digital-PCR assay for screening and quantitative monitoring of calreticulin (CALR) type-2 positive patients with myelofibrosis following allogeneic stem cell transplantation

Bone marrow transplantation (Basingstoke), 2016-06, Vol.51 (6), p.872-873

2016

Volltextzugriff (PDF)

Prognostic effect of calreticulin mutations in patients with myelofibrosis after allogeneic hematopoietic stem cell transplantation

Leukemia, 2014-07, Vol.28 (7), p.1552-1555

2014

Volltextzugriff (PDF)

Similar outcome of calreticulin type I and calreticulin type II mutations following RIC allogeneic haematopoietic stem cell transplantation for myelofibrosis

Bone marrow transplantation (Basingstoke), 2016-10, Vol.51 (10), p.1391-1393

2016

Volltextzugriff (PDF)

Lenalidomide as salvage therapy after allo-SCT for multiple myeloma is effective and leads to an increase of activated NK (NKp44 ) and T (HLA-DR ) cells

Bone marrow transplantation (Basingstoke), 2010-02, Vol.45 (2), p.349-353

2010

Volltextzugriff (PDF)

P1024: IMPACT OF TP53 IN MYELOFIBROSIS UNDERGOING STEM CELL TRANSPLANTATION

HemaSphere, 2022-06, Vol.6 (Suppl), p.914-915

2022

Volltextzugriff (PDF)

Screening and monitoring of MPL W515L mutation with real-time PCR in patients with myelofibrosis undergoing allogeneic-SCT

Bone marrow transplantation (Basingstoke), 2010-09, Vol.45 (9), p.1404-1407

2010

Volltextzugriff (PDF)

Low frequency of calreticulin mutations in MDS patients

Leukemia, 2014-09, Vol.28 (9), p.1933-1934

2014

Volltextzugriff (PDF)

Monitoring of minimal residual disease in multiple myeloma after allo-SCT: flow cytometry vs PCR-based techniques

Bone marrow transplantation (Basingstoke), 2008-05, Vol.41 (10), p.913-916

2008

Volltextzugriff (PDF)

Circulating CD34 cells as prognostic and follow-up marker in patients with myelofibrosis undergoing allo-SCT

Bone marrow transplantation (Basingstoke), 2012-01, Vol.47 (1), p.143-145

2012

Volltextzugriff (PDF)

Impact of the NK Cell Receptor LIR-1 (ILT-2/CD85j/LILRB1) on Cytotoxicity against Multiple Myeloma

Clinical & developmental immunology, 2012-01, Vol.2012 (2012), p.1-13

2012

Volltextzugriff (PDF)

Digital-PCR assay for screening and quantitative monitoring of calreticulin

Bone marrow transplantation (Basingstoke), 2016-06, Vol.51 (6), p.872

2016

Volltextzugriff (PDF)

Detection of disseminated epithelial cancer cells by liquid culture—factors interfering with the standardization of assays

Cytotherapy (Oxford, England), 2003, Vol.5 (3), p.252-258

2003

Volltextzugriff (PDF)

Circulating [CD34.sup.+] cells as prognostic and follow-up marker in patients with myelofibrosis undergoing allo-SCT

Bone marrow transplantation (Basingstoke), 2012-01, Vol.47 (1), p.143

2012

Volltextzugriff (PDF)

Lenalidomide as salvage therapy after allo-SCT for multiple myeloma is effective and leads to an increase of activated NK

Bone marrow transplantation (Basingstoke), 2010-02, Vol.45 (2), p.349

2010

Volltextzugriff (PDF)

Lenalidomide as salvage therapy after allo-SCT for multiple myeloma is effective and leads to an increase of activated NK cells

Bone marrow transplantation (Basingstoke), 2010-02, Vol.45 (2), p.349

2010

Volltextzugriff (PDF)

Immunomagnetic tumor cell selection—implications for the detection of disseminated cancer cells

Transfusion (Philadelphia, Pa.), 2000-12, Vol.40 (12), p.1489-1493

2000

Volltextzugriff (PDF)

Interference of cytokeratin-20 and mammaglobin-reverse-transcriptase polymerase chain assays designed for the detection of disseminated cancer cells

Medical oncology (Northwood, London, England), 2001-01, Vol.18 (1), p.33-38

2001

Volltextzugriff (PDF)

Urokinase-like plasminogen activator receptor expression on disseminated breast cancer cells

Journal of hematotherapy & stem cell research, 2001-02, Vol.10 (1), p.141-145

2001

Volltextzugriff (PDF)

Disseminated breast cancer cells prior to and after high-dose therapy

Journal of hematotherapy & stem cell research, 2001-10, Vol.10 (5), p.681-689

2001

Volltextzugriff (PDF)

Influence of preharvest tumor cell contamination in bone marrow or blood does not predict resultant tumor cell contamination of granulocyte colony-stimulating factor mobilized stem cells

Journal of hematotherapy & stem cell research, 2001-04, Vol.10 (2), p.303-307

2001

Volltextzugriff (PDF)

Comprehensive clinical-molecular transplant scoring system for myelofibrosis undergoing stem cell transplantation

Blood, 2019-05, Vol.133 (20), p.2233-2242

2019

Volltextzugriff (PDF)

Indication of Horizontal DNA Gene Transfer by Extracellular Vesicles

PloS one, 2016-09, Vol.11 (9), p.e0163665-e0163665

2016

Volltextzugriff (PDF)

Digital-droplet PCR assays for IDH, DNMT3A and driver mutations to monitor after allogeneic stem cell transplantation minimal residual disease of myelofibrosis

Bone marrow transplantation (Basingstoke), 2022-03, Vol.57 (3), p.510-512

2022

Volltextzugriff (PDF)

1 – 25 von 103

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(93)
Mit Volltextzugriff
(101)

Publikationsform

Artikel
(102)
Buchkapitel
(1)

Sprache

Englisch
(103)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Impact of molecular residual disease post allografting in myelofibrosis patients

Toxicity-reduced, myeloablative allograft followed by lenalidomide maintenance as salvage therapy for refractory/relapsed myeloma patients

Digital-PCR assay for screening and quantitative monitoring of calreticulin (CALR) type-2 positive patients with myelofibrosis following allogeneic stem cell transplantation

Prognostic effect of calreticulin mutations in patients with myelofibrosis after allogeneic hematopoietic stem cell transplantation

Similar outcome of calreticulin type I and calreticulin type II mutations following RIC allogeneic haematopoietic stem cell transplantation for myelofibrosis

Lenalidomide as salvage therapy after allo-SCT for multiple myeloma is effective and leads to an increase of activated NK (NKp44 ) and T (HLA-DR ) cells

P1024: IMPACT OF TP53 IN MYELOFIBROSIS UNDERGOING STEM CELL TRANSPLANTATION

Screening and monitoring of MPL W515L mutation with real-time PCR in patients with myelofibrosis undergoing allogeneic-SCT

Low frequency of calreticulin mutations in MDS patients

Monitoring of minimal residual disease in multiple myeloma after allo-SCT: flow cytometry vs PCR-based techniques

Circulating CD34 cells as prognostic and follow-up marker in patients with myelofibrosis undergoing allo-SCT

Impact of the NK Cell Receptor LIR-1 (ILT-2/CD85j/LILRB1) on Cytotoxicity against Multiple Myeloma

Digital-PCR assay for screening and quantitative monitoring of calreticulin

Detection of disseminated epithelial cancer cells by liquid culture—factors interfering with the standardization of assays

Circulating [CD34.sup.+] cells as prognostic and follow-up marker in patients with myelofibrosis undergoing allo-SCT

Lenalidomide as salvage therapy after allo-SCT for multiple myeloma is effective and leads to an increase of activated NK

Lenalidomide as salvage therapy after allo-SCT for multiple myeloma is effective and leads to an increase of activated NK cells

Immunomagnetic tumor cell selection—implications for the detection of disseminated cancer cells

Interference of cytokeratin-20 and mammaglobin-reverse-transcriptase polymerase chain assays designed for the detection of disseminated cancer cells

Urokinase-like plasminogen activator receptor expression on disseminated breast cancer cells

Disseminated breast cancer cells prior to and after high-dose therapy

Influence of preharvest tumor cell contamination in bone marrow or blood does not predict resultant tumor cell contamination of granulocyte colony-stimulating factor mobilized stem cells

Comprehensive clinical-molecular transplant scoring system for myelofibrosis undergoing stem cell transplantation

Indication of Horizontal DNA Gene Transfer by Extracellular Vesicles

Digital-droplet PCR assays for IDH, DNMT3A and driver mutations to monitor after allogeneic stem cell transplantation minimal residual disease of myelofibrosis

Suchergebnisse filtern